{"mainPropery":{"diseaseId":9239,"diseaseName":"Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9239/amyotrophic-lateral-sclerosis-parkinsonismdementia-complex-1","synonyms":["Amyotrophic lateral sclerosis, Parkinsonism/Dementia complex of Guam","Guam disease"],"synonyms-with-source":[{"name":"Amyotrophic lateral sclerosis, Parkinsonism/Dementia complex of Guam"},{"name":"Guam disease"}],"identifiers":[{"identifierType":"OMIM","identifierId":"105500"},{"identifierType":"ORPHANET","identifierId":"90020"},{"identifierType":"UMLS","identifierId":"C0543859"}]},"diseaseCategories":[{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":2652,"resourceName":"The ALS Association","abbreviation":"","address1":"1275 K Street, N.W.","address2":"Suite 250","address3":"","address4":"","address5":"","city":"Washington, DC","state":"","zip":"20005","country":"","phone":"202-407-8580","tty":"","tollFree":"1-800-782-4747","fax":"202-464-8869","email":"alsinfo@alsa-national.org","url":"http://www.alsa.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/105500' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=105500' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0543859' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022660' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=90020' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1742,"resourceId":2896,"resourceName":"RDCRN - Clinical Research in Amyotrophic Lateral Sclerosis and Related Disorders for Therapeutic Development","descriptionText":"The <a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/CREATE/index.htm\">Clinical Research in Amyotrophic Lateral Sclerosis and Related Disorders for Therapeutic Development (CREATE) Consortium</a> is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving sporadic and familial forms of amyotrophic lateral sclerosis, frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), and progressive muscular atrophy (PMA). The CREATE Consortium has a contact registry for patients who wish to be contacted about clinical research opportunities and updates on the progress of the research projects.\r\n<br />\r\n<br />\r\nFor more information on the registry see: <a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/registry/index.htm\">https://www.rarediseasesnetwork.org/registry/index.htm</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:105500' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":680,"dateCreated":"2020-08-28T12:03:00","publishDate":"2020-09-01T00:00:00","title":"NIH Announces New Transformative Research Award Program for ALS","description":"The National Institutes of Health plans to invest $25 million over 5 years in a new program to spur innovative research on amyotrophic lateral sclerosis (ALS), a progressive and fatal neurological disease that weakens and eventually paralyzes voluntary muscles. Accelerating Leading-edge Science in ALS (ALS2) aims to answer critical questions about this disease.","url":"https://www.nih.gov/news-events/news-releases/nih-announces-new-transformative-research-award-program-als","lastModified":"2020-09-03T13:45:00","isFeatured":false},{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":11444,"phenoTypeName":"Abnormal lower motor neuron morphology","percentRanges":"-"},{"phenoTypeId":13679,"phenoTypeName":"Amyotrophic lateral sclerosis","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":9377,"phenoTypeName":"Bulbar palsy","percentRanges":"-"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","percentRanges":"-"},{"phenoTypeId":5588,"phenoTypeName":"Muscle spasm","percentRanges":"-"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","percentRanges":"-"},{"phenoTypeId":13591,"phenoTypeName":"Paralysis","percentRanges":"-"},{"phenoTypeId":9388,"phenoTypeName":"Parkinsonism","percentRanges":"-"}],"medicalProducts":[{"productId":670,"genericName":"Edaravone","tradeName":"Radicava","tradeLink":"https://www.radicava.com/patient/","manufacturer":"","sponsor":"Mitsubishi Tanabe Pharma Corporation","indication":"May 2017, edaravone (Radicava) was approved for the treatment of amyotrophic lateral sclerosis (ALS).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/radicava","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a617027.html"}],"EncodedName":"Amyotrophic_lateral_sclerosis-parkinsonism_dementia_complex_1"}